Application of quantum dots-based biotechnology in cancer diagnosis: Current status and future perspectives

Journal of Nanomaterials

Volumn 2010, Issue , 2010, Pages

  Li, Yan ^a   Peng, Chun Wei ^b  

^a WUHAN UNIVERSITY   (China)

^b Hubei Cancer Clinical Study Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; CURRENT STATUS; DISTANT METASTASIS; EARLY DETECTION; FUTURE PERSPECTIVES; IN-VIVO; LYMPH NODE; MOLECULAR IMAGING; OVARIAN CANCERS; PANCREATIC CANCERS; PHOTOPHYSICAL PROPERTIES; PROSTATE CANCERS; QUANTUM DOT; SEMICONDUCTOR NANOCRYSTALS; TUMOR METASTASIS;

PATHOLOGY; SYNTHESIS (CHEMICAL); TUMORS;

SEMICONDUCTOR QUANTUM DOTS;

EID: 77951980901     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2010/676839     Document Type: Review

References (122)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA: A Cancer Journal for Clinicians 2009 59 4 225 249
2. Hoffman R. M., The multiple uses of fluorescent proteins to visualize cancer in vivo Nature Reviews Cancer 2005 5 10 796 806 (Pubitemid 41400779)
3. Hoffman R. M., Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins Clinical and Experimental Metastasis 2009 26 4 345 355
4. National Cancer Institute,. Cancer Nanotechnology Plan, http://nano.cancer.gov/about-alliance/cancer-nanotechnology-plan.asp
5. Cozzoli P. D., Pellegrino T., Manna L., Synthesis, properties and perspectives of hybrid nanocrystal structures Chemical Society Reviews 2006 35 11 1195 1208 (Pubitemid 44611729)
6. Nair P. S., Fritz K. P., Scholes G. D., Evolutionary shape control during colloidal quantum-dot growth Small 2007 3 3 481 487
7. Resch-Genger U., Grabolle M., Cavaliere-Jaricot S., Nitschke R., Nann T., Quantum dots versus organic dyes as fluorescent labels Nature Methods 2008 5 9 763 775
8. Pelley J. L., Daar A. S., Saner M. A., State of academic knowledge on toxicity and biological fate of quantum dots Toxicological Sciences 2009 112 2 276 296
9. Manzoor K., Johny S., Thomas D., Setua S., Menon D., Nair S., Bio-conjugated luminescent quantum dots of doped ZnS: a cyto-friendly system for targeted cancer imaging Nanotechnology 2009 20 6
10. Michalet X., Pinaud F. F., Bentolila L. A., Quantum dots for live cells, in vivo imaging, and diagnostics Science 2005 307 5709 538 544 (Pubitemid 40165671)
11. Reimann S. M., Manninen M., Electronic structure of quantum dots Reviews of Modern Physics 2002 74 4 1283 1342 (Pubitemid 36121907)
12. Gokarna A., Jin L.-H., Hwang J. S., Quantum dot-based protein micro- and nanoarrays for detection of prostate cancer biomarkers Proteomics 2008 8 9 1809 1818 (Pubitemid 351678281)
13. Marchal F., Pic E., Pons T., Dubertret B., Bolotine L., Guillemin F., Quantum dots in oncological surgery: the future for surgical margin status? Bulletin du Cancer 2008 95 12 1149 1153
14. Weng K. C., Noble C. O., Papahadjopoulos-Sternberg B., Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo Nano Letters 2008 8 9 2851 2857
15. Zhou M., Ghosh I., Quantum dots and peptides: a bright future together Biopolymers 2007 88 3 325 339
16. Erogbogbo F., Yong K.-T., Roy I., Xu G. X., Prasad P. N., Swihart M. T., Biocompatible luminescent silicon quantum dots for imaging of cancer cells ACS Nano 2008 2 5 873 878
17. Ben-Ari E. T., Nanoscale quantum dots hold promise for cancer applications Journal of the National Cancer Institute 2003 95 7 502 504
18. Hezinger A. F. E., Tessmar J., Gopferich A., Polymer coating of quantum dotsa powerful tool toward diagnostics and sensorics European Journal of Pharmaceutics and Biopharmaceutics 2008 68 1 138 152 (Pubitemid 350181411)
19. Yong K.-T., Roy I., Swihart M. T., Prasad P. N., Multifunctional nanoparticles as biocompatible targeted probes for human cancer diagnosis and therapy Journal of Materials Chemistry 2009 19 27 4655 4672
20. Medintz I. L., Mattousi H., Clapp A. R., Potential clinical applications of quantum dots International Journal of Nanomedicine 2008 3 2 151 167 (Pubitemid 352037849)
21. Dubertret B., Skourides P., Norris D. J., Noireaux V., Brivanlou A. H., Libchaber A., In vivo imaging of quantum dots encapsulated in phospholipid micelles Science 2002 298 5599 1759 1762
22. Smith A. M., Dave S., Nie S., True L., Gao X., Multicolor quantum dots for molecular diagnostics of cancer Expert Review of Molecular Diagnostics 2006 6 2 231 244
23. Zhang H., Yee D., Wang C., Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives Nanomedicine 2008 3 1 83 91
24. Smith A. M., Duan H., Mohs A. M., Nie S., Bioconjugated quantum dots for in vivo molecular and cellular imaging Advanced Drug Delivery Reviews 2008 60 11 1226 1240
25. Yezhelyev M. V., Al-Hajj A., Morris C., In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots Advanced Materials 2007 19 20 3146 3151
26. Mulder W. J. M., Castermans K., van Beijnum J. R., Molecular imaging of tumor angiogenesis using v 3-integrin targeted multimodal quantum dots Angiogenesis 2009 12 1 17 24
27. Tada H., Higuchi H., Wanatabe T. M., Ohuchi N., In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice Cancer Research 2007 67 3 1138 1144
28. Shah B. S., Clark P. A., Moioli E. K., Stroscio M. A., Mao J. J., Labeling of mesenchymal stem cells by bioconjugated quantum dots Nano Letters 2007 7 10 3071 3079
29. Yong K. T., Ding H., Roy I., Imaging pancreatic cancer using bioconjugated inp quantum dots ACS Nano 2009 3 3 502 510
30. Chen C., Peng J., Xia H.-S., Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer Biomaterials 2009 30 15 2912 2918
31. Smith B. R., Cheng Z., De A., Koh A. L., Sinclair R., Gambhir S. S., Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature Nano Letters 2008 8 9 2599 2606
32. Parungo C. P., Soybel D. I., Colson Y. L., Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics Annals of Surgical Oncology 2007 14 2 286 298
33. Lu H., Li B., Kang Y., Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting Cancer Chemotherapy and Pharmacology 2007 59 2 175 181
34. Hgdall E. V. S., Christensen L., Kjaer S. K., CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish MALOVA Ovarian Cancer Study Gynecologic Oncology 2007 104 3 508 515
35. Tothill R. W., Tinker A. V., George J., Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clinical Cancer Research 2008 14 16 5198 5208
36. Zheng Y., Katsaros D., Shan S. J. C., A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy Clinical Cancer Research 2007 13 23 6984 6992
37. Wang H.-Z., Wang H.-Y., Liang R.-Q., Ruan K.-C., Detection of tumor marker CA125 in ovarian carcinoma using quantum dots Acta Biochimica et Biophysica Sinica 2004 36 10 681 686
38. Nathwani B. B., Jaffari M., Juriani A. R., Mathur A. B., Meissner K. E., Fabrication and characterization of silk-fibroin-coated quantum dots IEEE Transactions on Nanobioscience 2009 8 1 72 77
39. Wu X., Liu H., Liu J., Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots Nature Biotechnology 2003 21 1 41 46
40. Harris L., Fritsche H., Mennel R., American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer Journal of Clinical Oncology 2007 25 33 5287 5312 (Pubitemid 350232263)
41. Slamon D. J., Godolphin W., Jones L. A., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 1989 244 4905 707 712
42. Goldhirsch A., Glick J. H., Gelber R. D., Coates A. S., Thurlimann B., Senn H. J., Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Annals of Oncology 2005 16 10 1569 1583 (Pubitemid 41511089)
43. Moasser M. M., The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis Oncogene 2007 26 45 6469 6487
44. Tsuda H., HER-2 (c-erbB-2) test update: present status and problems Breast Cancer 2006 13 3 236 248
45. Wolff A. C., Hammond M. E. H., Schwartz J. N., American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Journal of Clinical Oncology 2007 25 1 118 145
46. Li-Shishido S., Watanabe T. M., Tada H., Higuchi H., Ohuchi N., Reduction in nonfluorescence state of quantum dots on an immunofluorescence staining Biochemical and Biophysical Research Communications 2006 351 1 7 13
47. Xiao Y., Gao X., Gannot G., Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection International Journal of Cancer 2008 122 10 2178 2186
48. Freedland S. J., Hotaling J. M., Fitzsimons N. J., PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomesresults from the SEARCH database European Urology 2008 53 4 758 766
49. Noguchi M., Stamey T. A., McNeal J. E., Yemoto C. M., Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers Journal of Urology 2000 164 5 1596 1600
50. Smith R. A., Cokkinides V., Brawley O. W., Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening CA: A Cancer Journal for Clinicians 2009 59 1 27 41
51. Gao X., Cui Y., Levenson R. M., Chung L. W. K., Nie S., In vivo cancer targeting and imaging with semiconductor quantum dots Nature Biotechnology 2004 22 8 969 976
52. Shi C., Zhou G., Zhu Y., Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells European Journal of Histochemistry 2008 52 2 127 134
53. Azzazy H. M. E., Mansour M. M. H., Kazmierczak S. C., Nanodiagnostics: a new frontier for clinical laboratory medicine Clinical Chemistry 2006 52 7 1238 1246
54. Gao X., Chung L. W. K., Nie S., Quantum dots for in vivo molecular and cellular imaging Methods in Molecular Biology 2007 374 135 145 (Pubitemid 350183404)
55. Wang Y., Dossey A. M., Froude J. W. II, PSA fluoroimmunoassays using anti-PSA ScFv and quantum-dot conjugates Nanomedicine 2008 3 4 475 483
56. Barua S., Rege K., Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots Small 2009 5 3 370 376
57. Hruban R. H., Maitra A., Kern S. E., Goggins M., Precursors to pancreatic cancer Gastroenterology Clinics of North America 2007 36 4 831 849
58. Swierczynski S. L., Maitra A., Abraham S. C., Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays Human Pathology 2004 35 3 357 366
59. Montet X., Weissleder R., Josephson L., Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas Bioconjugate Chemistry 2006 17 4 905 911
60. Yang L., Mao H., Wang Y. A., Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging Small 2009 5 2 235 243
61. Yang L., Mao H., Cao Z., Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles Gastroenterology 2009 136 5 1514 1525
62. Qian J., Yong K.-T., Roy I., Imaging pancreatic cancer using surface-functionalized quantum dots Journal of Physical Chemistry B 2007 111 25 6969 6972
63. Fidler I. J., The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited Nature Reviews Cancer 2003 3 6 453 458
64. Weiss L., Metastasis of cancer: a conceptual history from antiquity to the 1990s Cancer and Metastasis Reviews 2000 19 3-4 193 383
65. Yong K.-T., Mn-doped near-infrared quantum dots as multimodal targeted probes for pancreatic cancer imaging Nanotechnology 2009 20 1 10
66. Karnoub A. E., Dash A. B., Vo A. P., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 2007 449 7162 557 563
67. Yoo J., Kambara T., Gonda K., Higuchi H., Intracellular imaging of targeted proteins labeled with quantum dots Experimental Cell Research 2008 314 19 3563 3569
68. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002 CA: A Cancer Journal for Clinicians 2005 55 2 74 108
69. Bruix J., Sherman M., Management of hepatocellular carcinoma Hepatology 2005 42 5 1208 1236
70. Llovet J. M., Burroughs A., Bruix J., Hepatocellular carcinoma Lancet 2003 362 9399 1907 1917
71. Thomas M. B., Zhu A. X., Hepatocellular carcinoma: the need for progress Journal of Clinical Oncology 2005 23 13 2892 2899
72. Morinaga T., Sakai M., Wegmann T. G., Tamaoki T., Primary structures of human -fetoprotein and its mRNA Proceedings of the National Academy of Sciences of the United States of America 1983 80 15 4604 4608
73. Smith C. J. P., Kelleher P. C., Alpha-fetoprotein molecular heterogeneity. Physiological correlations with normal growth, carcinogenesis and tumor growth Biochimica et Biophysica Acta 1980 605 1 1 32
74. Trevisani F., DIntino P. E., Morselli-Labate A. M., Serum -fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status Journal of Hepatology 2001 34 4 570 575
75. Yu X., Chen L., Deng Y., Fluorescence analysis with quantum dot probes for hepatoma under one- and two-photon excitation Journal of Fluorescence 2007 17 2 243 247
76. Yu X., Chen L., Li K., Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo Journal of Biomedical Optics 2007 12 1
77. Chen L.-D., Liu J., Yu X.-F., The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis Biomaterials 2008 29 31 4170 4176
78. Dowlatshahi K., Fan M., Snider H. C., Habib F. A., Lymph node micrometastases from breast carcinoma: reviewing the dilemma Cancer 1997 80 7 1188 1197
79. Kobayashi H., Kawamoto S., Bernardo M., Brechbiel M. W., Knopp M. V., Choyke P. L., Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging Journal of Controlled Release 2006 111 3 343 351
80. Jain R., Dandekar P., Patravale V., Diagnostic nanocarriers for sentinel lymph node imaging Journal of Controlled Release 2009 138 2 90 102
81. Kim S., Lim Y. T., Soltesz E. G., Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping Nature Biotechnology 2004 22 1 93 97
82. Bentolila L. A., Ebenstein Y., Weiss S., Quantum dots for in vivo small-animal imaging Journal of Nuclear Medicine 2009 50 4 493 496
83. Yong K.-T., Roy I., Ding H., Bergey E. J., Prasad P. N., Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications Small 2009 5 17 1997 2004
84. Ballou B., Ernst L. A., Andreko S., Sentinel lymph node imaging using quantum dots in mouse tumor models Bioconjugate Chemistry 2007 18 2 389 396
85. Purushotham A. D., Upponi S., Klevesath M. B., Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial Journal of Clinical Oncology 2005 23 19 4312 4321
86. Veronesi U., Paganelli G., Viale G., Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series Journal of the National Cancer Institute 1999 91 4 368 373
87. Crane-Okada R., Wascher R. A., Elashoff D., Giuliano A. E., Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer Annals of Surgical Oncology 2008 15 7 1996 2005
88. Lyman G. H., Giuliano A. E., Somerfield M. R., American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer Journal of Clinical Oncology 2005 23 30 7703 7720
89. Hama Y., Koyama Y., Urano Y., Choyke P. L., Kobayashi H., Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity Breast Cancer Research and Treatment 2007 103 1 23 28
90. Parungo C. P., Ohnishi S., Kim S.-W., Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging Journal of Thoracic and Cardiovascular Surgery 2005 129 4 844 850
91. Kobayashi H., Ogawa M., Kosaka N., Choyke P. L., Urano Y., Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents Nanomedicine 2009 4 4 411 419
92. Mohs A. M., Duan H. W., Kairdolf B. A., Smith A. M., Nie S. M., Proton-resistant quantum dots: stability in gastrointestinal fluids and implications for oral delivery of nanoparticle agents Nano Research 2009 2 6 500 508
93. Ballou B., Lagerholm B. C., Ernst L. A., Bruchez M. P., Waggoner A. S., Noninvasive imaging of quantum dots in mice Bioconjugate Chemistry 2004 15 1 79 86
94. Gao X., Yang L., Petros J. A., Marshall F. F., Simons J. W., Nie S., In vivo molecular and cellular imaging with quantum dots Current Opinion in Biotechnology 2005 16 1 63 72
95. Schipper M. L., Iyer G., Koh A. L., Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice Small 2009 5 1 126 134
96. Jayagopal A., Russ P. K., Haselton F. R., Surface engineering of quantum dots for in vivo vascular imaging Bioconjugate Chemistry 2007 18 5 1424 1433
97. Choi H. S., Ipe B. I., Misra P., Lee J. H., Bawendi M. G., Frangioni J. V., Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots Nano Letters 2009 9 6 2354 2359
98. Choi H. S., Liu W., Misra P., Renal clearance of quantum dots Nature Biotechnology 2007 25 10 1165 1170
99. Inoue Y., Izawa K., Yoshikawa K., Yamada H., Tojo A., Ohtomo K., In vivo fluorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring European Journal of Nuclear Medicine and Molecular Imaging 2007 34 12 2048 2056
100. Karabanovas V., Zakarevicius E., Sukackaite A., Streckyte G., Rotomskis R., Examination of the stability of hydrophobic (CdSe)ZnS quantum dots in the digestive tract of rats Photochemical and Photobiological Sciences 2008 7 6 725 729
101. Liu W., Choi H. S., Zimmer J. P., Tanaka E., Frangioni J. V., Bawendi M., Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications Journal of the American Chemical Society 2007 129 47 14530 14531
102. Chen Z., Chen H., Meng H., Bio-distribution and metabolic paths of silica coated CdSeS quantum dots Toxicology and Applied Pharmacology 2008 230 3 364 371
103. Cho S. J., Maysinger D., Jain M., Roder B., Hackbarth S., Winnik F. M., Long-term exposure to CdTe quantum dots causes functional impairments in live cells Langmuir 2007 23 4 1974 1980
104. Chan W.-H., Shiao N.-H., Lu P.-Z., CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals Toxicology Letters 2006 167 3 191 200
105. Hardman R., A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors Environmental Health Perspectives 2006 114 2 165 172
106. Li H., Zhou Q., Liu W., Yan B., Zhao Y., Jiang G., Progress in the toxicological researches for quantum dots Science in China, Series B 2008 51 5 393 400
107. Anas A., Akita H., Harashima H., Itoh T., Ishikawa M., Biju V., Photosensitized breakage and damage of DNA by CdSe-ZnS quantum dots Journal of Physical Chemistry B 2008 112 32 10005 10011
108. Lovric J., Bazzi H. S., Cuie Y., Fortin G. R. A., Winnik F. M., Maysinger D., Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots Journal of Molecular Medicine 2005 83 5 377 385
109. Mancini M. C., Kairdolf B. A., Smith A. M., Nie S., Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo Journal of the American Chemical Society 2008 130 33 10836 10837
110. Tang M., Xing T., Zeng J., Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons Environmental Health Perspectives 2008 116 7 915 922
111. Delehanty J. B., Mattoussi H., Medintz I. L., Delivering quantum dots into cells: strategies, progress and remaining issues Analytical and Bioanalytical Chemistry 2009 393 4 1091 1105
112. Drbohlavova J., Adam V., Kizek R., Hubalek J., Quantum dotscharacterization, preparation and usage in biological systems International Journal of Molecular Sciences 2009 10 2 656 673
113. Hild W. A., Breunig M., Goepferich A., Quantum dotsnano-sized probes for the exploration of cellular and intracellular targeting European Journal of Pharmaceutics and Biopharmaceutics 2008 68 2 153 168
114. Pong B.-K., Trout B. L., Lee J.-Y., Modified ligand-exchange for efficient solubilization of CdSe/ZnS quantum dots in water: a procedure guided by computational studies Langmuir 2008 24 10 5270 5276
115. Walling M. A., Novak J. A., Shepard J. R. E., Quantum dots for live cell and in vivo imaging International Journal of Molecular Sciences 2009 10 2 441 491
116. Higuchi Y., Oka M., Kawakami S., Hashida M., Mannosylated semiconductor quantum dots for the labeling of macrophages Journal of Controlled Release 2008 125 2 131 136
117. Bharali D. J., Lucey D. W., Jayakumar H., Pudavar H. E., Prasad P. N., Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy Journal of the American Chemical Society 2005 127 32 11364 11371
118. Smith A. M., Mohs A. M., Nie S., Tuning the optical and electronic properties of colloidal nanocrystals by lattice strain Nature Nanotechnology 2009 4 1 56 63
119. Smith A. M., Nie S., Next-generation quantum dots Nature Biotechnology 2009 27 8 732 733
120. Bawa R., Will the nanomedicine patent land grab thwart commercialization? Nanomedicine: Nanotechnology, Biology, and Medicine 2005 1 4 346 350
121. Flynn T., Wei C., The pathway to commercialization for nanomedicine Nanomedicine: Nanotechnology, Biology, and Medicine 2005 1 1 47 51
122. National Nanotechnology Initiative (NNI),. http://www.nano.gov